Following a Mediterranean diet, monitoring high blood pressure at home, and increasing efforts to ban smoking in public places top the list of new recommendations for reducing stroke risk from the American Heart Association/American Stroke Association.

Revised stroke prevention guidelines also expand the list of acceptable oral anticoagulant options for patients with nonvalvular atrial fibrillation beyond warfarin to include dabigatran, apixaban, and rivaroxaban.

“The selection of antithrombotic agent should be individualized on the basis of patient risk factors (particularly risk for intracranial hemorrhage), cost, tolerability, patient preference, potential for drug interactions, and other clinical characteristics, including time International Normalized Ratio (INR) is in therapeutic range for patients taking warfarin,” the writing committee wrote in the journal Stroke, published online Oct. 29.

Continue Reading

READ FULL ARTICLE Curated publisher From Medical Page Today